Aaron’s BCBUD Inc. Receives Confirmation of Readiness from Health Canada Print E-mail
Wednesday, 15 May 2019 06:48

VANCOUVER, British Columbia, May 15, 2019 (GLOBE NEWSWIRE)

VANCOUVER, British Columbia, May 15, 2019 (GLOBE NEWSWIRE) -- AARON’S BCBUD Inc. (“Aaron’s BCBUD” or the “Company”), a late stage cannabis cultivator applicant under Health Canada’s Cannabis Act, is pleased to announce that it has received its confirmation of readiness from Health Canada. This is the final step for Aaron’s BCBUD Inc. before Health Canada issues their cultivation license to produce cannabis under the Cannabis Act. This means that Aaron’s BCBUD Inc. is ready to start cultivation as soon as Health Canada has given them approval to begin production.

“We are very excited to receive our confirmation of readiness from Health Canada. This means that our dream is about to become reality and we are very excited to make the next step and start growing,” said Aaron’s BCBUD Inc. Founder and CEO William Marshall.

Once Aaron’s BCBUD Inc. receives their license for their purpose-built production facility on Vancouver Island they plan to immediately go into full production.  Using old school growing techniques, water sourced from local springs, black soil from mother earth and a lot of care and attention, Aaron’s BCBUD Inc. is looking to become the leader in high quality, premium cannabis. Their products will set the new standard of quality in Canadian cannabis by providing their customers with a product that is grown with care, the natural way.

About the company

Based in Vancouver BC, with their primary grow facility located on British Columbia’s Vancouver Island. Their grow facility will have ample space to produce up to 6000kg of dried cannabis annually. With an additional 20 acres of land for further expansion and plans to expand onsite facilities. Aaron’s BCBUD Inc. is fully privately financed.

Media Contact

William Marshall
Email: [email protected]
Website: AaronsBCBUD.com

Primary Logo

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!